<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="http://www.accessdata.fda.gov/spl/stylesheet/spl.xsl" type="text/xsl"?>
<document xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="urn:hl7-org:v3 http://www.accessdata.fda.gov/spl/schema/spl.xsd">
   <id root="725fb4ac-3bd2-4c0f-829f-a3a40863ebce"/>
   <code code="34391-3" codeSystem="2.16.840.1.113883.6.1" displayName="HUMAN PRESCRIPTION DRUG LABEL"/>
   <title>Flurbiprofen Sodium Ophthalmic Solution USP, 0.03%</title>
   <effectiveTime value="20100928"/>
   <setId root="725fb4ac-3bd2-4c0f-829f-a3a40863ebce"/>
   <versionNumber value="1"/>
   <author>
      <time/>
      <assignedEntity>
         <representedOrganization>
            <id extension="118802834" root="1.3.6.1.4.1.519.1"/>
            <name>Rebel Distributors Corp</name>
            <assignedEntity>
               <assignedOrganization>
                  <assignedEntity>
                     <assignedOrganization>
                        <id extension="118802834" root="1.3.6.1.4.1.519.1"/>
                        <name>Rebel Distributors Corp</name>
                     </assignedOrganization>
                     <performance>
                        <actDefinition>
                           <code code="C73607" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="RELABEL"/>
                        </actDefinition>
                     </performance>
                     <performance>
                        <actDefinition>
                           <code code="C73606" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="REPACK"/>
                        </actDefinition>
                     </performance>
                  </assignedEntity>
               </assignedOrganization>
            </assignedEntity>
         </representedOrganization>
      </assignedEntity>
   </author>
   <component>
      <structuredBody>
         <component>
            <section>
               <id root="1ac9ac87-424f-fa76-7d15-bdbe0563c0f5"/>
               <code code="48780-1" codeSystem="2.16.840.1.113883.6.1" displayName="SPL listing data elements section"/>
               <effectiveTime value="20080304"/>
               <subject>
                  <manufacturedProduct>
                     <manufacturedProduct>
                        <code codeSystem="2.16.840.1.113883.6.69" code="21695-615"/>
                        <name>Flurbiprofen Sodium</name>
                        <formCode code="C60992" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="SOLUTION/ DROPS"/>
                        <asEntityWithGeneric>
                           <genericMedicine>
                              <name>Flurbiprofen Sodium</name>
                           </genericMedicine>
                        </asEntityWithGeneric>
                        <asEquivalentEntity classCode="EQUIV">
                           <code code="C64637" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <definingMaterialKind>
                              <code code="24208-314" codeSystem="2.16.840.1.113883.6.69"/>
                           </definingMaterialKind>
                        </asEquivalentEntity>
                        <ingredient classCode="ACTIB">
                           <quantity>
                              <numerator value="0.242" unit="mg"/>
                              <denominator value="1" unit="mL"/>
                           </quantity>
                           <ingredientSubstance>
                              <code code="Z5B97MU9K4" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Flurbiprofen Sodium</name>
                              <activeMoiety>
                                 <activeMoiety>
                                    <code code="5GRO578KLP" codeSystem="2.16.840.1.113883.4.9"/>
                                    <name>FLURBIPROFEN</name>
                                 </activeMoiety>
                              </activeMoiety>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="2968PHW8QP" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Citric Acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="7FLD91C86K" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Edetate Disodium</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="QTT17582CB" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Hydrochloric Acid</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="532B59J990" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>POLYVINYL ALCOHOL</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="660YQ98I10" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Potassium Chloride</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="059QF0KO0R" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Water</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="451W47IQ8X" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Chloride</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="1Q73Q2JULR" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Citrate</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="55X04QC32I" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Sodium Hydroxide</name>
                           </ingredientSubstance>
                        </ingredient>
                        <ingredient classCode="IACT">
                           <ingredientSubstance>
                              <code code="2225PI3MOV" codeSystem="2.16.840.1.113883.4.9"/>
                              <name>Thimerosal</name>
                           </ingredientSubstance>
                        </ingredient>
                        <asContent>
                           <quantity>
                              <numerator value="2.5" unit="mL"/>
                              <denominator value="1"/>
                           </quantity>
                           <containerPackagedProduct>
                              <code code="21695-615-25" codeSystem="2.16.840.1.113883.6.69"/>
                              <formCode code="C43171" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="BOTTLE, DROPPER"/>
                           </containerPackagedProduct>
                        </asContent>
                     </manufacturedProduct>
                     <subjectOf>
                        <approval>
                           <id extension="ANDA074447" root="2.16.840.1.113883.3.150"/>
                           <code code="C73584" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="ANDA"/>
                           <author>
                              <territorialAuthority>
                                 <territory>
                                    <code code="USA" codeSystem="2.16.840.1.113883.5.28"/>
                                 </territory>
                              </territorialAuthority>
                           </author>
                        </approval>
                     </subjectOf>
                     <subjectOf>
                        <marketingAct>
                           <code code="C53292" codeSystem="2.16.840.1.113883.3.26.1.1"/>
                           <statusCode code="active"/>
                           <effectiveTime>
                              <low value="19950104"/>
                           </effectiveTime>
                        </marketingAct>
                     </subjectOf>
                     <consumedIn>
                        <substanceAdministration>
                           <routeCode code="C38287" codeSystem="2.16.840.1.113883.3.26.1.1" displayName="OPHTHALMIC"/>
                        </substanceAdministration>
                     </consumedIn>
                  </manufacturedProduct>
               </subject>
            </section>
         </component>
         <component>
            <section ID="i4i_description_id_1f4dfe83-6138-4ca8-8c21-563982138d98">
               <id root="565af86f-10bf-4bbd-affb-5865372308da"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34089-3" displayName="DESCRIPTION SECTION"/>
               <title>DESCRIPTION</title>
               <text>
                  <paragraph>Flurbiprofen Sodium Ophthalmic Solution USP, 0.03% is a sterile topical nonsteroidal anti-inflammatory product for ophthalmic use. Flurbiprofen sodium is represented by the following structural formula:</paragraph>
                  <renderMultiMedia referencedObject="id_5c1b88a8-d899-4696-a542-6aa5244deacd"/>
                  <paragraph>C<sub>15</sub>H<sub>12 </sub>FNaO<sub>2</sub> •2H<sub>2</sub>O</paragraph>
                  <paragraph>Mol. Wt. 302.27</paragraph>
                  <paragraph>Chemical Name: Sodium (±)-2-(2-fluoro-4-biphenyl)-propionate dihydrate.</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="emphasis">Each mL Contains: </content>
                     </content>ACTIVE: Flurbiprofen sodium 0.03%;</paragraph>
                  <paragraph>INACTIVES: Sodium Citrate, Polyvinyl Alcohol 1.4%, Edetate Disodium, Potassium Chloride, Sodium Chloride, Citric Acid, Purified Water. Hydrochloric Acid and/or Sodium Hydroxide may be added to adjust pH (6.0 – 7.0).</paragraph>
                  <paragraph>PRESERVATIVE ADDED: Thimerosal 0.005%.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
               <component>
                  <observationMedia ID="id_5c1b88a8-d899-4696-a542-6aa5244deacd">
                     <text>Chemical Structure</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="725fb4ac-3bd2-4c0f-829f-a3a40863ebce-01.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_clinical_pharmacology_id_12eaf2c8-56b1-4542-9110-3755b24d0365">
               <id root="5e7bc7ac-7f11-4088-b3fb-5dff748ffb17"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34090-1" displayName="CLINICAL PHARMACOLOGY SECTION"/>
               <title>CLINICAL PHARMACOLOGY</title>
               <text>
                  <paragraph>Flurbiprofen sodium is one of a series of phenylalkanoic acids that have shown analgesic antipyretic, and antiinflammatory activity in animal inflammatory diseases. Its mechanism of action is believed to be through inhibition of the cyclo-oxygenase enzyme that is essential in the biosynthesis of prostaglandins.</paragraph>
                  <paragraph>Prostaglandins have been shown in many animal models to be mediators of certain kinds of intraocular inflammation. In studies performed on animal eyes, prostaglandins have been shown to produce disruption of the blood-aqueous humor barrier, vasodilatation, increased vascular permeability, leukocytosis, and increased intraocular pressure.</paragraph>
                  <paragraph>Prostaglandins also appear to play a role in the miotic response produced during ocular surgery by constricting the iris sphincter independently of cholinergic mechanisms. In clinical studies, flurbiprofen sodium ophthalmic solution has been shown to inhibit the miosis induced during the course of cataract surgery.</paragraph>
                  <paragraph>Results from clinical studies indicate that flurbiprofen sodium has no significant effect upon intraocular pressure.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_indications_id_89852de2-3bb2-444e-93c1-50a9f8d07633">
               <id root="d324f6d5-7b80-46dd-bb50-5bd71c77cebf"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34067-9" displayName="INDICATIONS &amp; USAGE SECTION"/>
               <title>INDICATIONS AND USAGE</title>
               <text>
                  <paragraph>Flurbiprofen sodium ophthalmic solution is indicated for the inhibition of intraoperative miosis.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_contraindications_id_98353dad-57f7-4216-8fbc-208559199332">
               <id root="5082e493-6dc7-4113-aec9-731368e42212"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34070-3" displayName="CONTRAINDICATIONS SECTION"/>
               <title>CONTRAINDICATIONS</title>
               <text>
                  <paragraph>Flurbiprofen sodium ophthalmic solution is contraindicated in individuals who are hypersensitive to any components of the medication.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_warnings_id_4b3a174e-d8ec-4792-973b-1e9718da7fd1">
               <id root="87ea5685-2d84-4a93-87a1-2dee1a794a0a"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34071-1" displayName="WARNINGS SECTION"/>
               <title>WARNINGS</title>
               <text>
                  <paragraph>With nonsteroidal anti-inflammatory drugs, there exists the potential for increased bleeding due to interference with thrombocyte aggregation. There have been reports that flurbiprofen sodium ophthalmic solution may cause increased bleeding of ocular tissues in conjunction with ocular surgery.</paragraph>
                  <paragraph>There exists the potential for cross-sensitivity to acetylsalicylic acid and other nonsteroidal anti-inflammatory drugs. Therefore, caution should be used when treating individuals who have previously exhibited sensitivities to these drugs.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_precautions_id_5ab1384e-f937-4a06-8abf-08528013b881">
               <id root="5e73f706-d795-4aba-b8b3-da1f56e09104"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="42232-9" displayName="PRECAUTIONS SECTION"/>
               <title>PRECAUTIONS</title>
               <effectiveTime value="20080304"/>
               <component>
                  <section ID="i4i_precautions_general_id_5c466127-e17e-4c43-a79e-32f2f9bdaa58">
                     <id root="301144f7-766d-4f2f-bc2c-79e7b9d49a7f"/>
                     <code codeSystem="2.16.840.1.113883.6.1" code="34072-9" displayName="GENERAL PRECAUTIONS SECTION"/>
                     <title>General</title>
                     <text>
                        <paragraph>Wound healing may be delayed with the use of flurbiprofen sodium ophthalmic solution.</paragraph>
                        <paragraph>It is recommended that flurbiprofen sodium ophthalmic solution be used with caution in surgical patients with known bleeding tendencies or who are receiving other medications which may prolong bleeding time.</paragraph>
                     </text>
                     <effectiveTime value="20080304"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_interactions_id_f5f44aa2-5920-406b-84b9-d968c9f91afa">
                     <id root="902fe81f-5682-43c9-be44-0f62dec25bf9"/>
                     <code codeSystem="2.16.840.1.113883.6.1" code="34073-7" displayName="DRUG INTERACTIONS SECTION"/>
                     <title>Drug Interactions</title>
                     <text>
                        <paragraph>Interaction of flurbiprofen sodium ophthalmic solution with other topical ophthalmic medications has not been fully investigated.</paragraph>
                        <paragraph>Although clinical studies with acetylcholine chloride and animal studies with acetylcholine chloride or carbachol revealed no interference, and there is no known pharmacological basis for an interaction, there have been reports that acetylcholine chloride and carbachol have been ineffective when used in patients treated with flurbiprofen sodium ophthalmic solution.</paragraph>
                     </text>
                     <effectiveTime value="20080304"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_carcinogenesis_mutagenesis_fertility_id_87e38ef3-500d-448a-85b8-6aba3e8162ba">
                     <id root="2a078df5-8fdc-449a-b742-b09922a19cce"/>
                     <code codeSystem="2.16.840.1.113883.6.1" code="34083-6" displayName="CARCINOGENESIS &amp; MUTAGENESIS &amp; IMPAIRMENT OF FERTILITY SECTION"/>
                     <title>Carcinogenesis, mutagenesis, impairment of fertility</title>
                     <text>
                        <paragraph>Long-term studies in mice and/or rats have shown no evidence of carcinogenicity or impairment of fertility with flurbiprofen.</paragraph>
                        <paragraph>Long-term mutagenicity studies in animals have not been performed.</paragraph>
                     </text>
                     <effectiveTime value="20080304"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_pregnancy_id_c94ddda2-385c-44c1-b862-92b46cae4aea">
                     <id root="3937d7f3-e82b-4f69-b864-8f5f627a1c3d"/>
                     <code codeSystem="2.16.840.1.113883.6.1" code="42228-7" displayName="PREGNANCY SECTION"/>
                     <title>Pregnancy</title>
                     <text>
                        <paragraph>
                           <content styleCode="bold">
                              <content styleCode="emphasis">Pregnancy Category C. </content>
                           </content>Flurbiprofen has been shown to be embryocidal, delay parturition, prolong gestation, reduce weight, and/or slightly retard growth of fetuses when given to rats in daily oral doses of 0.4 mg/kg (approximately 67 times the human daily topical dose) and above. There are no adequate and well-controlled studies in pregnant women. Flurbiprofen sodium ophthalmic solution should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.</paragraph>
                     </text>
                     <effectiveTime value="20080304"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_nursing_mothers_id_82330e5b-8548-402c-9983-1d1b20de7f38">
                     <id root="2aacafba-66e6-4cde-a469-502508807791"/>
                     <code codeSystem="2.16.840.1.113883.6.1" code="34080-2" displayName="NURSING MOTHERS SECTION"/>
                     <title>Nursing mothers</title>
                     <text>
                        <paragraph>It is not known whether this drug is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from flurbiprofen sodium, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.</paragraph>
                     </text>
                     <effectiveTime value="20080304"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_pediatric_use_id_a1d8e13a-8b97-4e79-bf0d-553fd767af26">
                     <id root="630b8f83-0756-427f-a5c0-fbe8ece8c105"/>
                     <code codeSystem="2.16.840.1.113883.6.1" code="34081-0" displayName="PEDIATRIC USE SECTION"/>
                     <title>Pediatric use</title>
                     <text>
                        <paragraph>Safety and effectiveness in pediatric patients have not been established.</paragraph>
                     </text>
                     <effectiveTime value="20080304"/>
                  </section>
               </component>
               <component>
                  <section ID="i4i_geriatric_use_id_94bab61f-7e28-4be4-b2ec-014807dc0311">
                     <id root="91105371-e5ab-449f-b9cf-b4856297db48"/>
                     <code codeSystem="2.16.840.1.113883.6.1" code="34082-8" displayName="GERIATRIC USE SECTION"/>
                     <title>Geriatric use</title>
                     <text>
                        <paragraph>No overall differences in safety or effectiveness have been observed between elderly and younger patients</paragraph>
                     </text>
                     <effectiveTime value="20080304"/>
                  </section>
               </component>
            </section>
         </component>
         <component>
            <section ID="i4i_adverse_effects_id_85c8feb4-0b00-4149-817a-0498e5278940">
               <id root="6432a2bb-2eaf-416d-821d-17a491cf03b0"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34084-4" displayName="ADVERSE REACTIONS SECTION"/>
               <title>ADVERSE REACTIONS</title>
               <text>
                  <paragraph>Transient burning and stinging upon instillation and other minor symptoms of ocular irritation have been reported with the use of flurbiprofen sodium ophthalmic solution. Other adverse reactions reported with the use of flurbiprofen sodium ophthalmic solution include: fibrosis, miosis, and mydriasis.</paragraph>
                  <paragraph>Increased bleeding tendency of ocular tissues in conjunction with ocular surgery has also been reported.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_overdosage_id_f3599252-7103-478c-8125-5dd7e21ad4a2">
               <id root="64e1e78d-3412-4914-b83c-174d6dee2178"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34088-5" displayName="OVERDOSAGE SECTION"/>
               <title>Overdosage</title>
               <text>
                  <paragraph>Overdosage will not ordinarily cause acute problems. If accidentally ingested, drink fluids to dilute.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_dosage_admin_id_1128cf6d-b856-44d2-b0ec-03ce10f8dbb4">
               <id root="66b9d143-994d-43c9-a88e-5838b381e39a"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34068-7" displayName="DOSAGE &amp; ADMINISTRATION SECTION"/>
               <title>DOSAGE AND ADMINISTRATION</title>
               <text>
                  <paragraph>A total of four (4) drops of flurbiprofen sodium ophthalmic solution should be administered by instilling 1 drop approximately every 1/2 hour beginning 2 hours before surgery.</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_how_supplied_id_de47fcd9-255b-45ee-b4d7-2ad9f000cd02">
               <id root="44c2ed5f-dfc4-4889-915c-a4a4c62d0fc5"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="34069-5" displayName="HOW SUPPLIED SECTION"/>
               <title>HOW SUPPLIED</title>
               <text>
                  <paragraph>Flurbiprofen Sodium Ophthalmic Solution USP, 0.03% is supplied in a plastic bottle with a controlled drop tip in the following size:</paragraph>
                  <paragraph>2.5 mL - Prod. No. 31404</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="emphasis">DO NOT USE IF IMPRINTED “Protective Seal” WITH YELLOW IS NOT INTACT.</content>
                     </content>
                  </paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_storage_id_2b20e0b5-a74b-4c9a-8e6f-dd0c9accdd19">
               <id root="f897abb5-1010-49ae-b78a-9420360ad926"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="44425-7" displayName="STORAGE AND HANDLING SECTION"/>
               <title>Storage</title>
               <text>
                  <paragraph>Store between 15°–30°C (59°–86°F).</paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="emphasis">Rx only</content>
                     </content>
                  </paragraph>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="emphasis">FOR OPHTHALMIC USE ONLY</content>
                     </content>
                  </paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_section_id_60c367bc-4239-437f-8ea2-5e410358db9c">
               <id root="ff3a56d2-130c-4521-806a-e25bb8c22e75"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="42229-5" displayName="SPL UNCLASSIFIED SECTION"/>
               <title>Manufacturer Information</title>
               <text>
                  <paragraph>
                     <content styleCode="bold">
                        <content styleCode="emphasis">Bausch &amp; Lomb Incorporated</content>
                     </content>
                  </paragraph>
                  <paragraph>Tampa, Florida 33637</paragraph>
                  <paragraph>©Bausch &amp; Lomb Incorporated</paragraph>
                  <paragraph>Repackaged by:</paragraph>
                  <paragraph>
                     <content styleCode="bold">Rebel Distributors Corp</content>
                  </paragraph>
                  <paragraph>Thousand Oaks, CA 91320</paragraph>
               </text>
               <effectiveTime value="20080304"/>
            </section>
         </component>
         <component>
            <section ID="i4i_Principal_display_panel_id_98becf12-2b47-43f8-8ba0-34e44553f7f7">
               <id root="197394cb-34e6-4c0d-811c-a20c137ff274"/>
               <code codeSystem="2.16.840.1.113883.6.1" code="51945-4" displayName="PACKAGE LABEL.PRINCIPAL DISPLAY PANEL"/>
               <title>Principal Display Panel</title>
               <text>
                  <paragraph>
                     <renderMultiMedia referencedObject="id_79b5c646-ffff-4efa-ab78-5e702a245c38"/>
                  </paragraph>
               </text>
               <effectiveTime value="20100928"/>
               <component>
                  <observationMedia ID="id_79b5c646-ffff-4efa-ab78-5e702a245c38">
                     <text>Flurbiprofen Sodium 0.03%</text>
                     <value xsi:type="ED" mediaType="image/jpeg">
                        <reference value="725fb4ac-3bd2-4c0f-829f-a3a40863ebce-02.jpg"/>
                     </value>
                  </observationMedia>
               </component>
            </section>
         </component>
      </structuredBody>
   </component>
</document>